[144] Williams-Sonoma, Inc. SEC Filing

Rhea-AI Filing Summary

Williams-Sonoma, Inc. (WSM) has filed a Form 144 indicating the planned sale of insider shares under Rule 144.

• Shares to be sold: 75,000 common shares
• Estimated value: US$12,610,695.50 (based on the market price at filing)
• Broker: Merrill, 555 California St., San Francisco, CA 94103
• Planned sale date: 15 July 2025 on the NYSE
• Shares outstanding: 122,998,061, so the proposed sale equals roughly 0.06 % of shares outstanding
• Source of shares: 165,000 RSUs acquired on 16 April 2024 for cash consideration
• Recent insider activity: Laura Alber sold 30,000 shares on 29 May 2025 for gross proceeds of US$4,929,685.47

The filing provides notice that the seller (not expressly named for the current transaction, but Laura Alber is listed as the most recent seller) does not possess undisclosed material adverse information, a standard representation under Rule 144. No financial performance data or earnings metrics are included; the document is limited to insider sale disclosures.

Positive

• Regulatory transparency: The Form 144 gives timely notice of insider intent, reducing information asymmetry for investors.

Negative

• Insider selling pressure: Planned sale of 75,000 shares plus 30,000 already sold may be interpreted as reduced management confidence, albeit economically small.

Insights

Securities Analyst

TL;DR: Insider plans to sell ~US$12.6 m in stock—small relative to float, signal largely neutral.

Rule 144 filings are routine for executives liquidating vested equity. The 75,000-share block equates to only 0.06 % of WSM’s outstanding shares, which limits market impact. Combined with the 30,000 shares sold in May, total insider dispositions over three months reach ~US$17.6 m, still immaterial against WSM’s multi-billion-dollar market cap. No adverse information is asserted, and the sale may be under a 10b5-1 plan. I view the disclosure as neutral to the investment thesis, though investors may monitor for persistent selling trends.

Corporate Governance Expert

TL;DR: Consecutive insider sales could raise governance-watcher eyebrows; modestly negative sentiment.

Frequent executive sales can trigger perception risks, especially when clustered. While the percentage is small, the cumulative 105,000 shares filed/sold within a short window suggests the executive is tightening personal exposure ahead of FY26. The absence of any mention of a pre-arranged 10b5-1 plan in the signature section (date left blank) may heighten scrutiny. From a governance lens, this is a modest negative even if economically de minimis.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON STOCK	MERRILL 555 CALIFORNIA ST SAN FRANCISCO CA 94103	75000	12610695.50	122998061	07/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON STOCK	04/16/2024	RSU	WILLIAM SONOMA INC			165000	04/16/2024	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LAURA ALBER C/O WILLIAM SONOMA INC 3250 VAN NESS AVENUE SAN FRANCISCO CA 94109	WILLIAM SONOMA INC	05/29/2025	30000	4929685.47

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Williams-Sonoma (WSM) shares are proposed for sale in this Form 144?

75,000 common shares are scheduled for sale on 15 July 2025.

What is the estimated market value of the WSM shares to be sold?

The aggregate market value is US$12,610,695.50 based on prices at the time of filing.

Who executed recent insider sales of Williams-Sonoma stock?

Laura Alber sold 30,000 shares on 29 May 2025, generating US$4.93 million in gross proceeds.

How significant is the planned sale relative to WSM’s shares outstanding?

It represents approximately 0.06 % of the 122,998,061 shares outstanding.

On which exchange will the shares be sold and through which broker?

The sale is slated for the NYSE via Merrill, 555 California St., San Francisco.